我们访问的客户表示他们没有使用批准周期或控制来限制内容。
The customers interviewed for this article reported having no required approval cycle or controls to restrict content.
在药品的整个生命周期(自批准前阶段到病人使用)，都保持警惕，对药物存有的风险和带来的益处进行评估。
Vigilant assessment of the risks and benefits of medicines applies throughout the life cycle of a medicine - from the pre-approval stage to use by patients.
已经进入到生命周期的批准阶段的建议也可能被取消，原因可能是基于环境中的一个变化，或者另一个建议可能在生命周期中跳跃前进。
Proposals that advanced far into the approval phase of the lifecycle may be cancelled based upon a change in the environment, or another proposal may suddenly leap ahead in the lifecycle.
应用推荐